kras mutation and glutathion JCI Uncovering new therapeutic targets for
Uncovering new therapeutic targets for a common KRAS mutation behind cancer kras mutation and glutathion glynac Interplays of glucose metabolism in pancreatic ductal adenocarcinoma GlyNAC Supplementation Improves Glutathione Deficiency, Targeting mutated GTPase KRAS in tumor therapies ScienceDirect KRAS mutation shown to promote tumor evasion of innate immune surveillance in lung cancer
Pay in 4 interest-free payments of $7.10 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23



